Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21093930rdf:typepubmed:Citationlld:pubmed
pubmed-article:21093930lifeskim:mentionsumls-concept:C0026769lld:lifeskim
pubmed-article:21093930lifeskim:mentionsumls-concept:C0004358lld:lifeskim
pubmed-article:21093930lifeskim:mentionsumls-concept:C0020852lld:lifeskim
pubmed-article:21093930lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:21093930lifeskim:mentionsumls-concept:C0086272lld:lifeskim
pubmed-article:21093930lifeskim:mentionsumls-concept:C0449445lld:lifeskim
pubmed-article:21093930pubmed:issue1-2lld:pubmed
pubmed-article:21093930pubmed:dateCreated2011-3-9lld:pubmed
pubmed-article:21093930pubmed:abstractText2D-immunomics may be useful in the identification of autoantigens in neurological autoimmune diseases, but its application may be limited by denaturation of target proteins. Here we compared the capacity of a single or multiple antigens to elicit autoantibodies targeting multiple neural autoantigens by ELISA and 2D-immunomics. We induced experimental autoimmune encephalomyelitis (EAE) with MBP peptide(89-104), total MBP or spinal cord homogenate. Both techniques showed anti-MBP IgG only after immunization with total MBP. In addition, 2D-immunomics revealed the presence in EAE mice of autoantibodies targeting other neural proteins, some displaying partial sequence homology with MBP. The present finding by 2D-immunomics of multiple neural proteins targeted by autoantibodies generated by a single antigen may help to explain the complex autoimmune response observed in multiple sclerosis.lld:pubmed
pubmed-article:21093930pubmed:languageenglld:pubmed
pubmed-article:21093930pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21093930pubmed:citationSubsetIMlld:pubmed
pubmed-article:21093930pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21093930pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21093930pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21093930pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21093930pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21093930pubmed:statusMEDLINElld:pubmed
pubmed-article:21093930pubmed:monthMarlld:pubmed
pubmed-article:21093930pubmed:issn1872-8421lld:pubmed
pubmed-article:21093930pubmed:authorpubmed-author:BonettiBrunoBlld:pubmed
pubmed-article:21093930pubmed:authorpubmed-author:FarinazzoAles...lld:pubmed
pubmed-article:21093930pubmed:authorpubmed-author:FurlanRoberto...lld:pubmed
pubmed-article:21093930pubmed:authorpubmed-author:CecconiDaniel...lld:pubmed
pubmed-article:21093930pubmed:authorpubmed-author:MarconiSilvia...lld:pubmed
pubmed-article:21093930pubmed:authorpubmed-author:AnghileriElen...lld:pubmed
pubmed-article:21093930pubmed:authorpubmed-author:RuffiniFrance...lld:pubmed
pubmed-article:21093930pubmed:authorpubmed-author:MilliAlbertoAlld:pubmed
pubmed-article:21093930pubmed:authorpubmed-author:BarbieriFranc...lld:pubmed
pubmed-article:21093930pubmed:authorpubmed-author:GiniBeatriceBlld:pubmed
pubmed-article:21093930pubmed:authorpubmed-author:TuranoErmanna...lld:pubmed
pubmed-article:21093930pubmed:copyrightInfoCopyright © 2010 Elsevier B.V. All rights reserved.lld:pubmed
pubmed-article:21093930pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21093930pubmed:volume232lld:pubmed
pubmed-article:21093930pubmed:ownerNLMlld:pubmed
pubmed-article:21093930pubmed:authorsCompleteYlld:pubmed
pubmed-article:21093930pubmed:pagination63-7lld:pubmed
pubmed-article:21093930pubmed:meshHeadingpubmed-meshheading:21093930...lld:pubmed
pubmed-article:21093930pubmed:meshHeadingpubmed-meshheading:21093930...lld:pubmed
pubmed-article:21093930pubmed:meshHeadingpubmed-meshheading:21093930...lld:pubmed
pubmed-article:21093930pubmed:meshHeadingpubmed-meshheading:21093930...lld:pubmed
pubmed-article:21093930pubmed:meshHeadingpubmed-meshheading:21093930...lld:pubmed
pubmed-article:21093930pubmed:meshHeadingpubmed-meshheading:21093930...lld:pubmed
pubmed-article:21093930pubmed:meshHeadingpubmed-meshheading:21093930...lld:pubmed
pubmed-article:21093930pubmed:meshHeadingpubmed-meshheading:21093930...lld:pubmed
pubmed-article:21093930pubmed:meshHeadingpubmed-meshheading:21093930...lld:pubmed
pubmed-article:21093930pubmed:meshHeadingpubmed-meshheading:21093930...lld:pubmed
pubmed-article:21093930pubmed:meshHeadingpubmed-meshheading:21093930...lld:pubmed
pubmed-article:21093930pubmed:meshHeadingpubmed-meshheading:21093930...lld:pubmed
pubmed-article:21093930pubmed:meshHeadingpubmed-meshheading:21093930...lld:pubmed
pubmed-article:21093930pubmed:meshHeadingpubmed-meshheading:21093930...lld:pubmed
pubmed-article:21093930pubmed:meshHeadingpubmed-meshheading:21093930...lld:pubmed
pubmed-article:21093930pubmed:meshHeadingpubmed-meshheading:21093930...lld:pubmed
pubmed-article:21093930pubmed:meshHeadingpubmed-meshheading:21093930...lld:pubmed
pubmed-article:21093930pubmed:year2011lld:pubmed
pubmed-article:21093930pubmed:articleTitle2D immunomic approach for the study of IgG autoantibodies in the experimental model of multiple sclerosis.lld:pubmed
pubmed-article:21093930pubmed:affiliationDepartment of Neuroscience, University of Verona, Italy.lld:pubmed
pubmed-article:21093930pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21093930pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed